In contrast, tumor cells with higher levels of OLIG2 relative to ASCL1, such as Ascl1-CKO tumors, favor activation of an OPC/oligodendrocyte program and a less diffuse tumor phenotype (Fig. 10d). The gene discussed is OLIG2; the disease is neoplasm.